Published in
Elsevier, The Lancet Infectious Diseases, 7(20), p. 816-826, 2020
DOI: 10.1016/s1473-3099(20)30160-2
Links
Tools
Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
Journal article published in 2020 by
Park Ys,
Pedro M. Folegatti 
,
Folegatti Pm,
Mustapha Bittaye,
Amy Flaxman ,
Fernando Ramos Lopez,
Duncan Bellamy ,
Lopez Fr,
Alexandra Kupke,
Catherine Mair,
Rebecca Makinson ,
Jonathan Sheridan ,
Cornelius Rohde,
Sandro Halwe,
Yuji Jeong
and other authors.
,
Folegatti Pm,
Mustapha Bittaye,
Amy Flaxman ,
Fernando Ramos Lopez,
Duncan Bellamy ,
Lopez Fr,
Alexandra Kupke,
Catherine Mair,
Rebecca Makinson ,
Jonathan Sheridan ,
Cornelius Rohde,
Sandro Halwe,
Yuji Jeong
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 